Faron Pharmaceuticals: Inside Information: Faron to present updated BEXMAB data in frontline HR-MDS to FDA; complete remission rate substantially increased to 43%
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameFaron Pharmaceuticals Ltd.
-
Registration countryFinland
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









